CapWealth Advisors’s Organon & Co OGN Stock Holding History

CapWealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125,416	Closed	-$2.18M	–	106
2023 Q3	$2.18M	Buy	125,416 +7,707	+7%	+$161K	0.28%	55
2023 Q2	$2.45M	Buy	117,709 +1,999	+2%	+$43.5K	0.3%	53
2023 Q1	$2.72M	Sell	115,710 -2,163	-2%	-$58.1K	0.34%	54
2022 Q4	$3.29M	Buy	117,873 +2,538	+2%	+$64.9K	0.39%	54
2022 Q3	$2.7M	Buy	115,335 +5,305	+5%	+$160K	0.36%	55
2022 Q2	$3.71M	Buy	110,030 +4,437	+4%	+$155K	0.45%	54
2022 Q1	$3.69M	Buy	105,593 +11,608	+12%	+$397K	0.38%	61
2021 Q4	$2.86M	Buy	93,985 +20,396	+28%	+$664K	0.29%	62
2021 Q3	$2.41M	Buy	73,589 +55,483	+306%	+$1.78M	0.26%	63
2021 Q2	$548K	Buy	+18,106	New	+$596K	0.06%	82

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

CapWealth Advisors's OGN Position: Q4 2023 in Review

CapWealth Advisors sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 125,416 shares — an estimated $2.18M sold.

CapWealth Advisors first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $3.71M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

CapWealth Advisors reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
CapWealth Advisors sold 125,416 Organon & Co shares in Q4 2023, an estimated $2.18M.
CapWealth Advisors first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
CapWealth Advisors's Organon & Co position peaked at $3.71M in Q2 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on CapWealth Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.